Glycopeptide analgesics

Drugs of the Future

Volumn 26, Issue 6, 2001, Pages 561-576

  Polt, R ^a   Palian, M M ^a  

^a University of Arizona   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ENKEPHALIN DERIVATIVE; GLYCOPEPTIDE; GLYCOPEPTIDE ANALGESIC; LSZ 1025; LSZ 62; LSZ 916; MORPHINE; SAM 1095; UNCLASSIFIED DRUG;

ANALGESIA; ANTINOCICEPTION; AREA UNDER THE CURVE; BLOOD BRAIN BARRIER; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG POTENCY; DRUG SPECIFICITY; GLYCOSYLATION; HYDROGEN BOND; PEPTIDE SYNTHESIS; PROTEIN ASSEMBLY; PROTEIN TRANSPORT; REVIEW;

EID: 0034812006     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2001.026.06.668342     Document Type: Review

References (93)

1. Peptides: A boom in the making
2. The use of oxytocin
3. 25 Years of salmon calcitonin: From synthesis to therapeutic use
4. Salmon calcitonin nasal spray
5. Oral delivery of salmon calcitonin
6. Abarelix
7. The introduction of the LHRH agonist, goserelin (Zoladex) into clinical practice
8. A biodegradable delivery system for peptides: Preclinical experience with the gonadotropin-releasing hormone agonist Zoladex
9. Preclinical pharmacology of pramlintide in the rat: Comparisons with human and rat amylin
10. T-1249, Trimeris Inc.
11. Identification of two related pentapeptides from the brain with potent opiate agonist activity
12. The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog
13. Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with μ- and δ-receptors
14. Dynorphin-(1-13), an extraordinarily potent opioid peptide
15. Carbohydrates: A hostile scientific frontier becomes friendlier
16. Glycosylation reactions: Present status future directions
17. Recent progress in O-glycosylation methods and its application to natural product synthesis
18. Methods for anomeric carbon-linked and fused sugar amino acid synthesis: The gateway to artificial glycopeptides
19. The chemistry of O- and N-linked glycopeptides
20. A general approach to the synthesis of O- and N-linked glycopeptides
21. Synthetic methods of glycopeptide assembly and biological analysis of glycopeptide products
22. Chemical synthesis of some mono- and digalactosyl O-glycopeptides
23. Solid-phase synthesis of O-linked glycopeptide enkephalin analogs
24. Probing cell surface "glyco-architecture" through total synthesis. Immunological consequences of a human blood group determinant in a clustered mucin-like context
25. Convergent total synthesis of a tumor-associated mucin motif
26. Glycopeptide synthesis in solution and on the solid phase
27. Solid-phase synthesis of an O-linked glycopeptide based on benzyl-protected glycan approach
28. 3-α-D-Manp-1]-threonine-O-pfp as a building block in solid-phase synthesis of an O-linked dimannosyl glycopeptide
29. O-Glycopeptides: A simple beta-stereoselective glycosidation of serine and threonine via a favorable hydrogen bonding pattern
30. General methods for α- or β-O-Ser/Thr glycosides and glycopeptides. Solid-phase synthesis of O-glycosyl cyclic enkephalin analogs
31. Stereoselective synthesis of O-serinyl/threoninyl-2-acetamido-2-deoxy-α- or β-glycosides
32. Building blocks for glycopeptide synthesis: Glycosylation of 3-mercaptopropionic acid and Fmoc amino acids with unprotected carboxyl groups
33. Preparation of building blocks for glycopeptide synthesis by glycosylation of Fmoc amino acids having unprotected carboxyl groups
34. p-Alkoxybenzyl alcohol resin and p-alkoxybenzyloxycarbonylhydrazide resin for solid phasae synthesis of protected-peptide fragments
35. Preparation and application of the 5-(4-(9-fluorenylmethoxycarbonyl)aminomethyl-3,5-dimethyoxyphenoxy)valeric acid (PAL) handle for the solid phase synthesis of C-terminal amides under mild conditions
36. Solid-phase synthesis of protected peptide fragments using a trialkoxy-diphenyi-methyl ester resin
37. Peptide synthesis by a combination of solid-phase and solution method. 1. A new very acid-labile anchor group for the solid-phase synthesis of fully protected fragments
38. Solid-phase syntheses of O-linked glycopeptide sequences
39. Synthesis of glycopeptides with the TN and T antigen structures, and their coupling to bovine serum albumin
40. Head group and structure specific interactions of enkephalins and dynorphin with liposomes: Investigation by hydrophobic photolabeling
41. Membrane lipid phase as catalyst for peptide receptor interactions
42. Possible mechanisms of action of cobra snake venom cardiotoxins and bee venom melittin
43. Vesicle-bound conformation of melittin: Transferred nuclear overhauser enhancement analysis in the presence of perdeuterated phosphatidylcholine vesicles
44. A high affinity, μ-opioid receptor-selective enkephalin analog lacking an N-terminal tyrosine
45. Methionine-enkephalin related glycoconjugates
46. Bis-penicillamine enkephalins possess highly improved specificity toward δ opioid receptors
47. A novel cyclic opioid peptide analog showing high preference for μ-receptors
48. Antibacterial peptides designed as analogs or hybrids of cecropins and melittin
49. N-Terminal protected pentapeptide sequence found in the venom of the Philippine cobra
50. A novel acylated analogue of dynorphin A(1-11) amide as a κ opioid receptor antagonist
51. Synthesis using an Fmoc-based strategy and biological activities of some reduced peptide bond pseudopeptide analogues of dynorphin A1
52. The characterization of β-endorphin and related peptide hormones and neurotransmitters
53. Glycosylation of threonine of the repeating unit of RNA polymerase II with β-linked N-acetylglucosame leads to a turnlike structure
54. Cooperativity of carbohydrate moiety orientation and β-turn stability is determined by intramolecular hydrogen-bonds in protected glycopeptide models
55. Internally quenched fluorogenic, α-helical dimers of peptides and glycopeptides for the evaluation of the effect of glycosylation on the conformation of peptides
56. Glycosylation of synthetic peptides breaks helices. Phosphorylation results in distorted structure
57. Enkephalin-based drug design: Conformational analysis of O-linked glycopeptides by NMR and molecular modeling
58. O-Linked glycopeptides retain helicity in water
59. CNS drug design based on principles of blood-brain barrier transport
60. Transport of opioid peptides into the central nervous system
61. Bioavailability and transport of peptides and peptide drugs into the brain
62. Blood-brain barrier permeability and bioavailability of a highly potent and μ-selective opioid receptor antagonist, CTAP: Comparison with morphine
63. Group report: What is the molecular basis of opioid antinociception and how does this information point to new drug design?
64. Glucose transporter proteins in brain: Delivery of glucose to neurons and glia
65. Amino acid assignment to one of three blood-brain barrier acid carriers
66. 2 (Tyr-W-MIF-1) is transported from brain to the blood by peptide transport system 1
67. Peptides and blood-brain barrier transport
68. Pharmacological effects in vivo in brain by vector-mediated peptide drug delivery
69. A strategy for delivering peptides into the central nervous system by sequential metabolism
70. Glycopeptide enkephalin analogs produce analgesia in mice: Evidence for penetration of the blood-brain barrier
71. The effect of glycosylation on the uptake of an enkephalin analog into the central nervous system
72. Solid phase synthesis of C-terminal modified enkephalins
73. Synthesis and conformational analysis of a series of galactosyl enkephalin analogues showing high analgesic activity
74. 5] enkephalin derivatives containing D-glucose
75. D-Tyr-Ser-Gly-Phe-Leu-Thr, a highly preferential ligand for δ-opiate receptors
76. Development of conformationally constrained linear peptides exhibiting a high affinity and pronounced selectivity for δ opioid receptors
77. Improved bioavailability to the brain of glycosylated Met-enkephalin analogs
78. Glycopeptide analgesics derived from enkephalins
79. Enkephalin glycopeptide analogues produce analgesia with reduced dependence liability
80. Improvement of intestinal absorption of peptide drugs by glycosylation: Transport of tetrapeptide by the sodium ion-dependent D-glucose transporter
81. Transport characteristics of peptides and peptidomimetics: 1. N-methylated peptides as substrates for the oligopeptide transporter and P-glycoprotein in the intestinal mucosa
82. Practical glycopeptide analgesics: Blood-brain barrier transport and binding of glycosylated enkephalin analogs
83. The generation of peptide combinatorial libraries using tea-bag synthesis: Identification of B-cell epitopes
84. Glycosylation improves the brain delivery of Met-enkephalin analogs
85. Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides
86. Dermorphin and deltorphin glycosylated analogues: Synthesis and antinociceptive activity after systemic administration